The newest addition to the BGI pharma solutions offers pharmaceutical companies a customized solution that has played a key role in the global clinical trials and development of the first innovative anti-ovarian cancer precision medicine. Cambridge, MA – BGI Americas today announced the launch of OseqTMHereditary Cancer Panel (HCP) to support global clinical trials of […]
Proprietary enzymatic synthesis technology produces high quality sequences up to 3000 nucleotides long PISCATAWAY, N.J. and ATLANTA — GenScript®, the world’s leading gene synthesis provider, today at the American Association for Cancer Research launched a single-stranded DNA (ssDNA) service. The new service offers researchers access to high quality, pure ssDNA for CRISPR-based gene insertion, ultimately helping to accelerate the […]
SAN DIEGO–(BUSINESS WIRE)–Mar. 29, 2019– Illumina, Inc. (NASDAQ: ILMN) today announced that it has filed a patent infringement suit against BGI Group’s subsidiary, Latvia MGI Tech SIA, in the Düsseldorf Regional Court in Germany. The complaint alleges that BGI’s sequencing products, including the BGISeq-500, MGISeq-2000, and related chemistry reagents, infringe EP 1 530 578 B1. This patent covers […]
– Applied DNA to Receive Staged Payments Totaling $5M Over the Next Four-Months – – Agreement Calls for Annual Payment Minima that Scale from $7 Million in Year 3 to $20 Million in Year 15 – – Applied DNA Technology to Power ETCH BioTrace System to Verify Legal Cannabis and Hemp Markets Globally – STONY […]
Following earlier LabCorp strategic investment, Mission Bio single cell-sequencing technology will be used by LabCorp to support clinical trials, along with the evaluation of potential applications in clinical diagnostics and companion diagnostics development SOUTH SAN FRANCISCO, Calif. (March 28, 2019) Mission Bio, the pioneer in high-throughput single-cell DNA analysis and precision genomics, today announced that […]
— Integrated Workflow Combines NanoString’s GeoMx DSP High-Plex RNA Assays and Bio-Techne’s Highly Sensitive RNAscope Imaging Reagent Portfolio — MINNEAPOLIS — Bio-Techne (NASDAQ:TECH), a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities, and NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research […]
AACR 2019 includes over 30 abstracts building on QIAGEN’s Sample to Insight solutions to advance understanding of cancer and commitment to improve outcomes Germantown, Maryland, and Hilden, Germany – QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the launch of new solutions designed to advance cancer research as part of its highlights at the […]
TUCSON, Ariz. — HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a diagnostic company whose mission is to advance precision medicine, today announced it has released a new HTG EdgeSeq Mouse mRNA Tumor Response Panel available now in the United States and Europe. The HTG EdgeSeq Mouse mRNA Tumor Response Panel is designed for use in mouse oncology models to identify and quantify expression […]
Complete Integrated Solution includes High-Throughput Instrument, Validated Protein & RNA Panels, and Integrated Data Analysis Software SEATTLE — NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced the commercial availability of the GeoMx™ Digital Spatial Profiler during the American Association of Cancer Research (AACR) conference being held March 29th – […]
• Combining piggyBac™ transposon technology with Lonza’s GS Xceed® expression system results in stable CHO pools with high levels of recombinant protein expression • The GS piggyBac™ system offers benefits for bioprocessing, particularly for challenging low-expressing proteins, helping to generate high-performing pools for material supply • Ability to insert large amounts of DNA into the host […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
